A federal appeals court did not rebuke a standard the Federal Trade Commission imposes for substantiating health claims, as the dietary supplement industry hoped, in a ruling on a complaint alleging misleading memory claims for the Prevagen cognitive health supplement.
FTC can proceed with litigation against [Quincy Bioscience LLC] after the US Court of Appeals for the Second Circuit vacated a district court
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?